<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url><loc>https://www.cato-reference.com/news/</loc><lastmod>2026-11-03</lastmod><changefreq>daily</changefreq><priority>0.8</priority></url>
  <url><loc>https://www.cato-reference.com/news/entecavir-stereoisomers-glycosidic-hydrolysis-deficiency-response.html</loc><lastmod>2026-11-03</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/losartan-potassium-elemental-impurities-tetrazole-route.html</loc><lastmod>2026-11-03</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/nifedipine-photostability-ortho-nitro-three-pathways.html</loc><lastmod>2026-11-03</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/iohexol-o-alkylation-regioisomer-impurity.html</loc><lastmod>2026-11-02</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/methotrexate-nitrosamine-pteridine-aromatic-amine.html</loc><lastmod>2026-11-02</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/piperacillin-sodium-dioxopiperazine-polymer-hapten.html</loc><lastmod>2026-11-02</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/isoniazid-hydrazine-genotoxic-impurity-dual-origin.html</loc><lastmod>2026-10-31</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/oseltamivir-phosphate-degradation-axes-citrate-amide.html</loc><lastmod>2026-10-31</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/warfarin-sodium-isopropanol-clathrate-disproportionation.html</loc><lastmod>2026-10-31</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ciclosporin-congener-limits-three-tier-specification.html</loc><lastmod>2026-10-30</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/posaconazole-alkali-stable-forced-degradation-method-blindspot.html</loc><lastmod>2026-10-30</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/rivaroxaban-three-carbonyls-hydrolysis-degradation.html</loc><lastmod>2026-10-30</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/itraconazole-cis-dioxolane-four-stereoisomers.html</loc><lastmod>2026-10-29</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/olanzapine-thiophene-oxidation-formulation-degradation.html</loc><lastmod>2026-10-29</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/tacrolimus-degradation-metal-catalyzed-rearrangement.html</loc><lastmod>2026-10-29</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/levothyroxine-sodium-hydrate-disproportionation-t3-limit.html</loc><lastmod>2026-10-28</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/meropenem-polymerized-impurities-hpsec-2d-lc.html</loc><lastmod>2026-10-28</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/paclitaxel-c7-epimer-ep-impurity-e.html</loc><lastmod>2026-10-28</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/cefuroxime-axetil-diastereomer-hydrolysis-dissolution.html</loc><lastmod>2026-10-27</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/vancomycin-hydrochloride-fermentation-related-substances.html</loc><lastmod>2026-10-27</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/voriconazole-stereoisomer-c2-epimerization.html</loc><lastmod>2026-10-27</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/dapagliflozin-related-substances-method-blind-spots.html</loc><lastmod>2026-10-26</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/montelukast-sodium-sulfoxide-diastereomer-control.html</loc><lastmod>2026-10-26</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/moxifloxacin-hydrochloride-degradation-impurity-profile.html</loc><lastmod>2026-10-26</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/iodixanol-chloropropanol-genotoxic-impurities.html</loc><lastmod>2026-10-25</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ritonavir-polymorph-form-ii-solubility-trap.html</loc><lastmod>2026-10-25</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/sitagliptin-phosphate-degradation-impurity-profile.html</loc><lastmod>2026-10-25</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/azithromycin-two-site-nitrosamine.html</loc><lastmod>2026-10-24</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/carbamazepine-polymorph-dihydrate-transformation.html</loc><lastmod>2026-10-24</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/linezolid-fluoro-morpholinoaniline-process-impurity.html</loc><lastmod>2026-10-24</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/acetaminophen-aminophenol-50ppm-vs-1000ppm.html</loc><lastmod>2026-10-23</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/amoxicillin-polymer-impurities-g10.html</loc><lastmod>2026-10-23</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/dexamethasone-betamethasone-epimer-rrt.html</loc><lastmod>2026-10-23</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/dabigatran-etexilate-capsule-reference-product-reverse-engineering.html</loc><lastmod>2026-10-22</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/levetiracetam-enantiomer-control-chromophore-free.html</loc><lastmod>2026-10-22</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/osimertinib-mesylate-genotoxic-impurities.html</loc><lastmod>2026-10-22</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/clopidogrel-bisulfate-chiral-purity-control.html</loc><lastmod>2026-10-21</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/imatinib-mesylate-polymorph-alpha-beta.html</loc><lastmod>2026-10-21</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/valsartan-tablet-dissolution-be-risk.html</loc><lastmod>2026-10-21</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/olmesartan-medoxomil-degradation-impurity-profile.html</loc><lastmod>2026-10-20</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ranitidine-hydrochloride-ndma-not-in-impurity-profile.html</loc><lastmod>2026-10-20</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/vonoprazan-fumarate-stability-study-design.html</loc><lastmod>2026-10-20</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/rivaroxaban-impurity-reference-standard-selection.html</loc><lastmod>2026-10-19</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/rosuvastatin-calcium-degradation-impurity-profile.html</loc><lastmod>2026-10-19</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ticagrelor-impurity-limit-setting-basis.html</loc><lastmod>2026-10-19</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/amlodipine-besylate-degradation-impurity-profile.html</loc><lastmod>2026-10-18</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/edoxaban-tosylate-sulfonate-ester-genotoxic-impurities.html</loc><lastmod>2026-10-18</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/esomeprazole-sodium-formulation-excipient-compatibility.html</loc><lastmod>2026-10-18</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/amlodipine-nitrosamine-impurities.html</loc><lastmod>2026-10-17</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/apixaban-degradation-impurity-profile.html</loc><lastmod>2026-10-17</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/tofacitinib-citrate-process-impurities.html</loc><lastmod>2026-10-17</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/acetylcysteine-degradation-impurity-profile.html</loc><lastmod>2026-10-16</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/dapagliflozin-elemental-impurities-residual-solvents.html</loc><lastmod>2026-10-16</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/moxifloxacin-hydrochloride-chiral-impurity-separation.html</loc><lastmod>2026-10-16</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/atorvastatin-calcium-degradation-impurity-profile.html</loc><lastmod>2026-10-14</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/metformin-hydrochloride-nitrosamine-impurities.html</loc><lastmod>2026-10-14</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/sitagliptin-phosphate-chiral-impurity-separation.html</loc><lastmod>2026-10-14</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/rivaroxaban-nitrosamine-impurities.html</loc><lastmod>2026-10-13</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/rosuvastatin-calcium-pharmacopoeia-impurity-comparison.html</loc><lastmod>2026-10-13</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ticagrelor-degradation-impurity-profile.html</loc><lastmod>2026-10-13</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/apixaban-genotoxic-impurities-from-route-to-control.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/pharmacopoeia-listed-vs-unlisted-reference-strategy.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/same-api-different-salt-impurity-naming.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/tinib-kinase-inhibitor-impurity-coverage.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/sartan-arb-impurity-comparison.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/supplier-catalog-numbering-vs-pharmacopoeia.html</loc><lastmod>2026-10-11</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/top-impurity-series-varieties.html</loc><lastmod>2026-10-12</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/ep-usp-chp-impurity-reference-standard-comparison.html</loc><lastmod>2026-10-10</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
  <url><loc>https://www.cato-reference.com/news/nitrosamine-impurities-control-guide.html</loc><lastmod>2026-10-10</lastmod><changefreq>monthly</changefreq><priority>0.7</priority></url>
</urlset>